Progress in Chemical and Biochemical Research

The Impact of Administering (S)-4-[1-(2, 3-dimethylphenyl) ethyl]-1H-imidazole (Dexmedetomidine) During Surgery on Immediate and Long-Term Pain after Simple Mastectomy: A Systematic Review

Ali Sharifi; Fariborz Rousta

Volume 7, Issue 2 , May 2024, , Pages 154-167

https://doi.org/10.48309/pcbr.2024.424520.1312

Abstract

Introduction: This systematic review will evaluate the impact of administering dexmedetomidine during surgery on immediate and long-term pain outcomes after simple mastectomy. By synthesizing ... Read More Introduction: This systematic review will evaluate the impact of administering dexmedetomidine during surgery on immediate and long-term pain outcomes after simple mastectomy. By synthesizing the available evidence, the review aims to provide a comprehensive understanding of the potential benefits of (S)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole: dexmedetomidine in this specific surgical context and inform clinical practice.Material and Methods: An extensive exploration of electronic databases, specifically PubMed, Embase, and the Cochrane Library, was undertaken to pinpoint pertinent studies (during 2000-2023). The search methodology encompassed a fusion of medical subject headings (MeSH) terms and keywords pertinent to "dexmedetomidine," "mastectomy"," Simple Mastectomy" and "postoperative pain." The search was confined to studies available in the English language. Moreover, the reference lists of identified articles and conference proceedings underwent manual scrutiny to unearth any supplementary studies of relevance.Results: Regarding postoperative pain intensity, the majority of studies reported significantly lower pain scores in the (S)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole: dexmedetomidine group compared to the control group at various time points during the immediate postoperative period(p˂0.05). (S)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole: dexmedetomidine infusion was associated with reduced pain intensity(p˂0.05), both at rest and with movement(p˃0.05), indicating improved analgesia(p˂0.05).Conclusion: Administering (S)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole: dexmedetomidine during surgery for simple mastectomy may have a positive impact on immediate and long-term pain outcomes. (S)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole: dexmedetomidine infusion is associated with reduced postoperative pain intensity, decreased opioid consumption, prolonged duration of analgesia, and improved patient satisfaction.Material: A narrative synthesis of the included studies will be conducted to summarize the characteristics, interventions, and outcomes of the studies. The findings will be presented in a tabular format. If deemed appropriate and feasible, a meta-analysis will be performed to calculate pooled effect sizes using appropriate statistical methods (Mantel-Haenszel or inverse variance methods) for the primary outcome measures.Results:The majority of the included studies reported postoperative pain scores as an outcome measure. The findings consistently demonstrated that both acetaminophen and NSAIDs were effective in reducing postoperative pain after esophagectomy. However, no significant differences were observed between the two analgesic options in terms of pain scores. Both groups showed comparable pain relief during the immediate postoperative period.Conclusion: based on the available evidence, both acetaminophen and NSAIDs are effective options for postoperative pain management after esophagectomy. Both analgesics demonstrate comparable efficacy in alleviating pain, reducing opioid consumption, prolonging the time to first analgesic request, and ensuring patient satisfaction. The decision regarding the choice of analgesic should consider individual patient characteristics, comorbidities, and potential adverse effects.

The Impact of Administering (S)-4-[1-(2, 3-dimethylphenyl) ethyl]-1H-imidazole (Dexmedetomidine) during Surgery on Immediate and Long-Term Pain after Simple Mastectomy: A Systematic Review

Fariborz Rousta; Ali Sharifi

Volume 7, Issue 1 , January 2024, , Pages 100-113

https://doi.org/10.48309/pcbr.2024.424516.1311

Abstract

Investigating the Hemodynamic Responses of Women Candidates for Elective Cesarean Section to Two Drugs, Bupivacaine and Ropivacaine: a Systematic Review

Bahman Naghipour; Vahideh Rahmani

Volume 6, Issue 2 , May 2023, , Pages 110-122

https://doi.org/10.22034/pcbr.2023.388101.1253

Abstract

Background: Since the minimum effective dose of the two drugs bupivacaine and Ropivacaine has not been included in the anesthesia reference books and different doses have been suggested ... Read More

Progress in Chemical and Biochemical Research

Articles in Press

Current Issue

Volume 7 (2024)

Volume 6 (2023)

Volume 5 (2022)

Volume 4 (2021)

Volume 3 (2020)

Volume 2 (2019)

Volume 1 (2018)

Author = Rahmani, Vahideh

The Impact of Administering (S)-4-[1-(2, 3-dimethylphenyl) ethyl]-1H-imidazole (Dexmedetomidine) During Surgery on Immediate and Long-Term Pain after Simple Mastectomy: A Systematic Review

Abstract

The Impact of Administering (S)-4-[1-(2, 3-dimethylphenyl) ethyl]-1H-imidazole (Dexmedetomidine) during Surgery on Immediate and Long-Term Pain after Simple Mastectomy: A Systematic Review

Abstract

Investigating the Hemodynamic Responses of Women Candidates for Elective Cesarean Section to Two Drugs, Bupivacaine and Ropivacaine: a Systematic Review

Abstract